Back to Search
Start Over
Severe Leukocyte Adhesion Deficiency-I (LAD-I) Lentiviral-Mediated Ex-Vivo Gene Therapy: Ongoing Phase 1/2 Study Results
- Source :
- Clinical Immunology. 250:109354
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Immunology
Immunology and Allergy
Subjects
Details
- ISSN :
- 15216616
- Volume :
- 250
- Database :
- OpenAIRE
- Journal :
- Clinical Immunology
- Accession number :
- edsair.doi...........22af1492020d6ebcf52898d2db2690b2
- Full Text :
- https://doi.org/10.1016/j.clim.2023.109354